Eric Topol from the Scripps Translational Science Institute envisions a future in which individualized medicine — a term he prefers over personalized or precision medicine — is fueled by a 'panoromic' view of that person's genome, microbiome, epigenome, and all the other omes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Personal Gut

Changes to Gut Bugs

What's Healthy?

From Mom's Genes

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.